This year's forum unites key players from Direct Biologics, Rion, Aegle Therapeutics, Aruna Bio, EXO Biologics, and more, accelerating towards the first-ever exosome & EV approval.

This is your opportunity to gain actionable insights and takeaways across 3-days to roadmap the path from discovery through commercialization to develop efficacious therapies for regenerative and precision medicine.